Drug
SHR-1918 placebo
SHR-1918 placebo is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_1
1
25%
Ph phase_3
2
50%
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 32 (50.0%)
Trials by Status
unknown125%
completed250%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
completedphase_2
Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic
NCT06109831
recruitingphase_3
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
NCT07230730
completedphase_3
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
NCT06723652
unknownphase_1
Safety and Tolerability of SHR-1918 in Healthy Subjects
NCT05432544
Clinical Trials (4)
Showing 4 of 4 trials
NCT06109831Phase 2
Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic
NCT07230730Phase 3
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
NCT06723652Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
NCT05432544Phase 1
Safety and Tolerability of SHR-1918 in Healthy Subjects
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4